Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavna Kumar

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
Surgery|July 10, 2012
Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokinesEric Luedke, Alena Cristina Jaime-Ramirez, Neela Bhave, et al.
Head & Neck|September 18, 2009
Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell linesJ Chad Brenner, Martin P Graham, Bhavna Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cellsTakeharu Kanazawa, Pavan K Kommareddi, Toshihide Iwashita, et al.
Oncotarget|April 21, 2017
DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinomaEric A Smith, Bhavna Kumar, Kakajan Komurov, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 23, 2008
Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancerBhavna Kumar, Kitrina G Cordell, Nisha D'Silva, et al.
Oncotarget|February 27, 2016
High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-statusBhavna Kumar, Nicole V Brown, Benjamin J Swanson, et al.
Molecular Therapy Oncolytics|April 28, 2016
ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinomaJi Young Yoo, Jun-Ge Yu, Azeem Kaka, et al.
Molecular Cancer Therapeutics|July 16, 2005
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xLJoshua A Bauer, Douglas K Trask, Bhavna Kumar, et al.
Journal of Receptor and Signal Transduction Research|August 26, 2017
Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cellsRashidul Haque, P Michael Iuvone, Li He, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
Surgery|July 10, 2012
Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokinesEric Luedke, Alena Cristina Jaime-Ramirez, Neela Bhave, et al.
Head & Neck|September 18, 2009
Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell linesJ Chad Brenner, Martin P Graham, Bhavna Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cellsTakeharu Kanazawa, Pavan K Kommareddi, Toshihide Iwashita, et al.
Oncotarget|April 21, 2017
DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinomaEric A Smith, Bhavna Kumar, Kakajan Komurov, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 23, 2008
Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancerBhavna Kumar, Kitrina G Cordell, Nisha D'Silva, et al.
Oncotarget|February 27, 2016
High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-statusBhavna Kumar, Nicole V Brown, Benjamin J Swanson, et al.
Molecular Therapy Oncolytics|April 28, 2016
ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinomaJi Young Yoo, Jun-Ge Yu, Azeem Kaka, et al.
Molecular Cancer Therapeutics|July 16, 2005
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xLJoshua A Bauer, Douglas K Trask, Bhavna Kumar, et al.
Journal of Receptor and Signal Transduction Research|August 26, 2017
Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cellsRashidul Haque, P Michael Iuvone, Li He, et al.
Pageof 7